Horváth Z - Search Results

1

Diagnostic yield of five minutes compared to three minutes hyperventilation during electroencephalography.

Craciun L, Varga ET, Mindruta I, Meritam P, Horváth Z, Terney D, Gardella E, Alving J, Vécsei L, Beniczky S. Craciun L, et al. Among authors: horvath z. Seizure. 2015 Aug;30:90-2. doi: 10.1016/j.seizure.2015.06.003. Epub 2015 Jun 14. Seizure. 2015. PMID: 26216691 Free article.

2

Current medical aspects of pantethine.

Horváth Z, Vécsei L. Horváth Z, et al. Ideggyogy Sz. 2009 Jul 30;62(7-8):220-9. Ideggyogy Sz. 2009. PMID: 19685700 Review.

3

Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.

Dézsi L, Horváth Z, Vécsei L. Dézsi L, et al. Among authors: horvath z. Expert Opin Drug Metab Toxicol. 2016 Nov;12(11):1343-1358. doi: 10.1080/17425255.2016.1214715. Epub 2016 Aug 22. Expert Opin Drug Metab Toxicol. 2016. PMID: 27428464

4

[The significance of Chlamydia pneumoniae in selected neurologic disorders].

Horváth Z, Vécsei L. Horváth Z, et al. Ideggyogy Sz. 2006 Jan 20;59(1-2):4-16. Ideggyogy Sz. 2006. PMID: 16491568 Review. Hungarian.

5

[Clinical features and diagnosis of spinocerebellar ataxia].

Klivényi P, Horváth Z, Vécsei L. Klivényi P, et al. Among authors: horvath z. Ideggyogy Sz. 2004 Jan 20;57(1-2):11-22. Ideggyogy Sz. 2004. PMID: 15042864 Review. Hungarian.

6

OLD AND NEW NEUROENDOCRINE MOLECULES: SOMATOSTATIN, CYSTEAMINE, PANTETHINE AND KYNURENINE.

Vécsei L, Horváth Z, Tuka B. Vécsei L, et al. Among authors: horvath z. Ideggyogy Sz. 2014 Mar 30;67(3-4):107-12. Ideggyogy Sz. 2014. PMID: 26118251 Review.

7

Protein kinase inhibitor as a potential candidate for epilepsy treatment.

Gajda Z, Török R, Horváth Z, Szántai-Kis C, Orfi L, Kéri G, Szente M. Gajda Z, et al. Among authors: horvath z. Epilepsia. 2011 Mar;52(3):579-88. doi: 10.1111/j.1528-1167.2011.02979.x. Epub 2011 Mar 3. Epilepsia. 2011. PMID: 21371019 Free article.

8

[Changes in epilepsy care during the first medical emergency period of COVID-19 pandemic in Hungary: A questionnaire survey].

Fabó D, Horváth Z, Klivényi P, Kamondi A. Fabó D, et al. Among authors: horvath z. Orv Hetil. 2020 Nov 15;161(46):1939-1943. doi: 10.1556/650.2020.32003. Print 2020 Nov 15. Orv Hetil. 2020. PMID: 33190124 Hungarian.

9

Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.

Kéri G, Székelyhidi Z, Bánhegyi P, Varga Z, Hegymegi-Barakonyi B, Szántai-Kis C, Hafenbradl D, Klebl B, Muller G, Ullrich A, Erös D, Horváth Z, Greff Z, Marosfalvi J, Pató J, Szabadkai I, Szilágyi I, Szegedi Z, Varga I, Wáczek F, Orfi L. Kéri G, et al. Among authors: horvath z. Assay Drug Dev Technol. 2005 Oct;3(5):543-51. doi: 10.1089/adt.2005.3.543. Assay Drug Dev Technol. 2005. PMID: 16305311 Review.

10

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma.

Czudor Z, Balogh M, Bánhegyi P, Boros S, Breza N, Dobos J, Fábián M, Horváth Z, Illyés E, Markó P, Sipos A, Szántai-Kis C, Szokol B, Őrfi L. Czudor Z, et al. Among authors: horvath z. Bioorg Med Chem Lett. 2018 Feb 15;28(4):769-773. doi: 10.1016/j.bmcl.2018.01.002. Epub 2018 Jan 2. Bioorg Med Chem Lett. 2018. PMID: 29329658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

455 results

Search Page